| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8219352 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 8 Pages |
Abstract
In the treatment for unresectable biliary tract cancer, the addition of ILBT to RT has no impact on OS or DSS but is associated with better LC. Therefore, the role of ILBT should be addressed by other measures than survival benefit, for example, by less toxicity, prolonged biliary tract patency decreasing the need for further palliative interventions, or patient quality of life.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yasuo MD, Kazuhiko MD, Hirobumi MD, Hiroshi MD, Naoto MD, Tetsuro MD, Takashi MD, Kazuo MD, Masao MD, Yoshinori MD, Makoto MD, Mitsuhiro MD, Katsuyuki MD, Hisayasu MD, Michiko MD, Yasuhiro MD, Hideya MD, Fumiaki MD, Yasumasa MD,